Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
about
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience.Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.
P2860
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
@en
type
label
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
@en
prefLabel
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
@en
P2093
P2860
P356
P1476
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection
@en
P2093
Andrew H Talal
Ira M Jacobson
Jaroslaw Pillardy
Marija Zeremski
Rositsa B Dimova
Ype P de Jong
P2860
P304
P356
10.1093/INFDIS/JIW332
P407
P577
2016-08-02T00:00:00Z